Home Featured Page 8

Featured

Latest

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

Pα+ Psychedelic Bulletin #183:

Transpersonal Connections, the Body’s Memory, and the Collaborative Nature of Consciousness

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

How to Create Your Own Psychedelic Integration Circle

Real-World Data Reveals Variability in Access to, and Use of, Spravato

The ‘Nada Effect’: Why Psychedelics Don’t Work for Everyone

Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters

Pα+ Psychedelic Bulletin #172: Lykos Scales Back IIT Program, CEO Steps...

The Great Reconnector: Finding Our Way Back Together With Psychedelics

Breathwork, Holding Space, and the Healing Power of Connection: Documenting the...

Exclusive: David Hough on Lykos’ Path to Resubmission

Psychedelics and Addiction Recovery: Microdosing and Redefining the Path to Sobriety

1...789...277 Page 8 of 277

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

Pα+ Psychedelic Bulletin #183:

Transpersonal Connections, the Body’s Memory, and the Collaborative Nature of Consciousness

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

How to Create Your Own Psychedelic Integration Circle

Real-World Data Reveals Variability in Access to, and Use of, Spravato

The ‘Nada Effect’: Why Psychedelics Don’t Work for Everyone

Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters

Pα+ Psychedelic Bulletin #172: Lykos Scales Back IIT Program, CEO Steps...

The Great Reconnector: Finding Our Way Back Together With Psychedelics

Breathwork, Holding Space, and the Healing Power of Connection: Documenting the...

Exclusive: David Hough on Lykos’ Path to Resubmission

Psychedelics and Addiction Recovery: Microdosing and Redefining the Path to Sobriety

EDITOR PICKS

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY